top of page
N1’s dual-engine (peptide and polymer) powered technology platform is combined with its proprietary data-driven transporter discovery. Molecular transporters enable drug molecules of different sizes and properties to overcome biological barriers and drug resistance.
The company has established its fast-growing and sustainable model that utilizes the platform’s great and widely applicable potential for both its in-house pipelines and co-development partnerships. N1 Life’s R&D program covers areas from oncology to dermatology, ophthalmology, neurological diseases, and infectious diseases.
bottom of page